Qiming U.S. Healthcare Fund II, L.P. - 30 Sep 2025 SCHEDULE 13G/A Report for Jasper Therapeutics, Inc. Voting Common Stock, par value $0.0001 (JSPR)

Filing Manager
Qiming U.S. Healthcare Fund II, L.P.
Reporting Manager
Qiming U.S. Healthcare Fund II, L.P.
Security
Jasper Therapeutics, Inc. Voting Common Stock, par value $0.0001
Symbol
JSPR
Shares outstanding
28,150,424 shares
Disclosed Ownership
928,964 shares
Ownership
3.3%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 17:22:30 UTC
Date of event
30 Sep 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Qiming U.S. Healthcare Fund II, L.P. 3.3% 928,964 0 928,964 /s/ Mark McDade By Qiming U.S. Healthcare GP II, LLC, its general partner, By Mark McDade, Managing Partner
Qiming U.S. Healthcare GP II, LLC 3.3% 928,964 0 928,964 /s/ Mark McDade Mark McDade, Managing Partner
Mark McDade 3.3% 928,964 0 928,964 /s/ Mark McDade Mark McDade
GARY E RIESCHEL 3.3% 928,964 0 928,964 /s/ Gary Rieschel Gary Rieschel